Average Co-Inventor Count = 2.03
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Pfizer Corporation (32 from 4,455 patents)
2. Hydra Biosciences, Inc. (12 from 49 patents)
3. Neurogen Corporation (10 from 305 patents)
4. Eli Lilly and Company (2 from 4,442 patents)
5. Novartis International Pharmaceutical, Ltd. (2 from 29 patents)
6. Kamari Pharma Ltd. (2 from 2 patents)
7. Boehringer Ingelheim International Gmbh (1 from 1,535 patents)
8. Exithera Pharmaceuticals, Inc. (1 from 6 patents)
9. Exlthera Pharmaceuticals, Inc. (1 from 1 patent)
62 patents:
1. 12435061 - Compounds and compositions for use in treating skin disorders
2. 12152014 - Therapeutic compounds and compositions
3. 11958854 - Substituted xanthines and methods of use thereof
4. 11807621 - Compounds and compositions for use in treating skin disorders
5. 11691962 - Therapeutic compounds and compositions
6. 11208409 - Substituted xanthines and methods of use thereof
7. 10519158 - Inhibiting the transient receptor potential A1 ion channel
8. 10428072 - Inhibiting the transient receptor potential A1 ion channel
9. 10399982 - Substituted xanthines and methods of use thereof
10. 10329292 - Substituted xanthine derivatives
11. 10221177 - Inhibiting the transient receptor potential A1 ion channel
12. 9969736 - Substituted xanthines and methods of use thereof
13. 9745272 - Quinazoline-2,4(1 H,3H)-dione derivatives
14. 9447114 - Thieno- and furo[2,3-d]pyrimidine-2,4[1H,3H]-dione derivatives
15. 9440972 - Pyrido[2,3-d]pyrimidine-2,4(1 H,3H)-dione derivatives